Skip to content

MEDIX: what changed

BE 0476.325.824Other company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€185,152
2024 · €103,076+€82,075
Equity
€458,642
2024 · €274,323+€184,319
Cash
€483,669
2024 · €259,834+€223,835
Balance sheet total
€511,835
2024 · €311,252+€200,583

Largest movements

2024 to 2025
Assets
  • Cash +€223,835

    up €223,835 (+86.1%), from €259,834 to €483,669

    mainly Net result for the year (+€185,152) and Receivables within one year (+€44,916)

  • Receivables within one year -€44,916

    down €44,916 (-97.4%), from €46,107 to €1,191

    of which Trade receivables: -€43,280

  • Deferred charges and accrued income +€21,664

    up €21,664 (+408%), from €5,311 to €26,974

Equity and liabilities
  • Reserves +€184,319

    up €184,319 (+70.4%), from €261,923 to €446,242

    of which Distributable reserves: +€185,152

  • Tax, wage and social debts +€17,710

    up €17,710 (+163%), from €10,857 to €28,567

Income statement
  • Gross operating margin +€64,372

    up €64,372 (+30.7%), from €209,608 to €273,981

  • Financial charges -€53,657

    down €53,657 (-96.5%), from €55,606 to €1,949

  • Taxes +€37,493

    up €37,493 (+75.5%), from €49,671 to €87,164

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result.

Result 2024 €103,076
Gross operating margin +€64,372
Staff costs +€663
Other operating charges -€138
Financial income +€1,013
Financial charges +€53,657
Taxes -€37,493
Result 2025 €185,152
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€224,668
Investment €0
Financing -€833
Cash 2024 €259,834
Net result for the year +€185,152
Receivables within one year +€44,916
Deferred charges and accrued income -€21,664
Trade debts +€1,507
Tax, wage and social debts +€17,710
Other debts -€2,952
Contributions, distributions and other -€833
Cash 2025 €483,669
brings cash intakes cash out
Every line side by side 37 lines
Line Code 2024 2025 Change %
Total assets 20/58 €311,252 €511,835 +€200,583 +64.4%
Current assets 29/58 €311,252 €511,835 +€200,583 +64.4%
Amounts receivable within one year 40/41 €46,107 €1,191 -€44,916 -97.4%
Trade receivables 40 €44,471 €1,191 -€43,280 -97.3%
Other amounts receivable 41 €1,636 €0 -€1,636 -100%
Current investments 50/53 €0 - =
Cash at bank and in hand 54/58 €259,834 €483,669 +€223,835 +86.1%
Deferred charges and accrued income 490/1 €5,311 €26,974 +€21,664 +408%
Total equity and liabilities 10/49 €311,252 €511,835 +€200,583 +64.4%
Equity 10/15 €274,323 €458,642 +€184,319 +67.2%
Contributions 10/11 €12,400 €12,400 = 0.0%
Reserves 13 €261,923 €446,242 +€184,319 +70.4%
Non-distributable reserves 130/1 €1,027 €194 -€833 -81.1%
Own shares acquired 1312 €1,027 €194 -€833 -81.1%
Distributable reserves 133 €260,896 €446,048 +€185,152 +71.0%
Profit (loss) carried forward 14 €0 €0 =
Amounts payable 17/49 €36,928 €53,193 +€16,264 +44.0%
Amounts payable within one year 42/48 €36,928 €53,193 +€16,264 +44.0%
Trade debts 44 - €1,507 +€1,507
Suppliers 440/4 - €1,507 +€1,507
Taxes, remuneration and social security 45 €10,857 €28,567 +€17,710 +163%
Taxes 450/3 €10,857 €28,567 +€17,710 +163%
Other amounts payable 47/48 €26,071 €23,119 -€2,952 -11.3%
Accrued charges and deferred income 492/3 €0 - =
Remuneration, social security and pensions 62 €1,269 €607 -€663 -52.2%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €0 - =
Other operating charges 640/8 €212 €350 +€138 +65.0%
Gross operating margin 9900 €209,608 €273,981 +€64,372 +30.7%
Operating profit (loss) 9901 €208,127 €273,024 +€64,897 +31.2%
Financial income 75/76B €227 €1,241 +€1,013 +446%
Recurring financial income 75 €227 €1,241 +€1,013 +446%
Financial charges 65/66B €55,606 €1,949 -€53,657 -96.5%
Recurring financial charges 65 €55,606 €1,949 -€53,657 -96.5%
Profit (loss) for the period before taxes 9903 €152,748 €272,316 +€119,568 +78.3%
Income taxes 67/77 €49,671 €87,164 +€37,493 +75.5%
Profit (loss) for the period 9904 €103,076 €185,152 +€82,075 +79.6%
Profit (loss) for the period to be appropriated 9905 €103,076 €185,152 +€82,075 +79.6%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Value of the equity

Indication, not a valuation or advice
€711,336 to €904,141

Midpoint €791,671 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate. Change the assumptions and the value follows.

Adjusted equity €458,642
Capitalised earnings €964,029 to €1.3m
Indication €711,336 to €904,141

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€458,642
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€458,642

Capitalised earnings

net result for the year (9904)
2025
€185,152
2024
€103,076
2023
€116,664
2022
€5,965
2021
€23,143
Average result
€134,964
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€964,029 / €1.1m / €1.3m

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 20 November 2026 via checked.be.